Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe + rosuvastatin vs rosuvastatin 10 mg in primary hypercholesterolemia
CTR20202110Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ezetimibe + rosuvastatin in hypercholesterolemia, sponsored by Sanofi. Started Oct 2020; status: completed.
02
Drugs
ezetimibe + rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on CTR20202110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202110.